SANOFI-AVENTIS
Patent Owner
Stats
- 112 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Sep 28, 2017 most recent publication
Details
- 112 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 5,178 Total Citation Count
- Oct 21, 1981 Earliest Filing
- 399 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8800759 Bushing for receiving a dropper neck, and corresponding package and kitJun 28, 13Aug 12, 14[B65D]
8801056 Motor vehicle front or rear assembly comprising an element for fastening trim elements to the body shell of the vehicleOct 12, 11Aug 12, 14[B60R]
8680096 Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulatorsDec 03, 10Mar 25, 14[A61K, C07D, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0273,936 USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITYAbandonedNov 09, 16Sep 28, 17[A61K]
2013/0203,651 PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROMEAbandonedJan 21, 11Aug 08, 13[A61K]
2012/0282,710 LIGAND BINDING DOMAINS OF NUCLEAR RECEPTORS IN CONTROLLABLE FORM AND METHODS INVOLVING THE SAMEAbandonedJul 17, 12Nov 08, 12[G01N]
2012/0122,923 DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, THEIR SYNTHESIS AND THERAPEUTIC USESAbandonedDec 11, 08May 17, 12[A61K, C07D, A61P]
2012/0108,464 TEST SYSTEMS, METHODS AND USES INVOLVING AS160 PROTEINAbandonedJan 27, 10May 03, 12[C12Q, C12N, G01N, C40B]
2012/0094,986 ANTICANCER DERIVIATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOFAbandonedMar 22, 10Apr 19, 12[A61K, C07D, A61P]
2012/0065,153 AZASUGAR DERIVATIVES, HEPARANASE INHIBITORS, METHOD FOR PREPARING SAME, COMPOSITIONS CONTAINING SAME, USE THEREOFAbandonedSep 08, 11Mar 15, 12[A61K, C07H, A61P]
2012/0004,207 THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL-AND PIPERIDINYL-ALKYL CARBAMATESAbandonedSep 09, 11Jan 05, 12[A61K, C07D, A61P]
8088797 -pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereofExpiredJun 24, 09Jan 03, 12[A01N]
2011/0312,934 2-ALKYL-6-CYCLOAMINO-3-(PYRIDIN-4-YL)IMIDAZO[1,2-B]-PYRIDAZINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOFAbandonedAug 12, 09Dec 22, 11[A61K, C07D, A61P]
8080547 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereofExpiredOct 06, 09Dec 20, 11[A61K, C07D]
8071297 Method for the diagnosis and treatment of cardiovascular diseasesExpiredNov 23, 06Dec 06, 11[C07H, C12Q, C12P]
8071601 Aminoquinoline derivatives and their use as adenosine A3 ligandsExpiredJan 18, 11Dec 06, 11[A61K, C07D]
8063045 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activityExpiredFeb 01, 10Nov 22, 11[A61K, C07D]
8063061 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereofExpiredApr 09, 08Nov 22, 11[A61K, C07D]
8044078 Amino-alkyl amide derivatives as CCR3 receptor ligandsExpiredMar 19, 08Oct 25, 11[A61K, C07D, C07C, A61P]
2011/0257,021 USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDERAbandonedApr 28, 11Oct 20, 11[C40B]
2011/0257,392 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOFAbandonedJun 27, 11Oct 20, 11[C07D]
2011/0251,194 ANTINEOPLASTIC DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOFAbandonedJan 07, 11Oct 13, 11[A61K, C07D, A61P]
2011/0251,385 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOFAbandonedJun 27, 11Oct 13, 11[C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
